UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.126

Sortiert nach

A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs

Journal of veterinary internal medicine, 2015-07, Vol.29 (4), p.1006-1012

2015

Volltextzugriff (PDF)

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document

Veterinary & comparative oncology, 2015-09, Vol.13 (3), p.176-183

2015

Volltextzugriff (PDF)

Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document

Veterinary & comparative oncology, 2010-03, Vol.8 (1), p.28-37

2010

Volltextzugriff (PDF)

Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours

Veterinary & comparative oncology, 2012-09, Vol.10 (3), p.194-205

2012

Volltextzugriff (PDF)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

Journal of veterinary internal medicine, 2018-01, Vol.32 (1), p.394-405

2018

Volltextzugriff (PDF)

Conduct, Oversight, and Ethical Considerations of Clinical Trials in Companion Animals with Cancer: Report of a Workshop on Best Practice Recommendations

Journal of veterinary internal medicine, 2016-03, Vol.30 (2), p.527-535

2016

Volltextzugriff (PDF)

Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma

Veterinary & comparative oncology, 2018-03, Vol.16 (1), p.E23-E29

2018

Volltextzugriff (PDF)

Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs

Journal of small animal practice, 2013-02, Vol.54 (2), p.67-74

2013

Volltextzugriff (PDF)

Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer

Cancer investigation, 2000, Vol.18 (8), p.781-792

2000

Volltextzugriff (PDF)

Efficacy of Radiation Therapy for the Treatment of Sialocele in Dogs

Journal of veterinary internal medicine, 2018-01, Vol.32 (1), p.107-110

2018

Volltextzugriff (PDF)

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

Journal of veterinary internal medicine, 2017-05, Vol.31 (3), p.872-878

2017

Volltextzugriff (PDF)

Phosphorus(III)-Mediated Stereoconvergent Formal [4+1]-Cycloannulation of 1,2-Dicarbonyls and o‑Quinone Methides: A Multicomponent Assembly of 2,3-Dihydrobenzofurans

Organic letters, 2016-09, Vol.18 (18), p.4514-4517

2016

Volltextzugriff (PDF)

Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma

Journal of veterinary internal medicine, 2014-09, Vol.28 (5), p.1569-1574

2014

Volltextzugriff (PDF)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs

Journal of veterinary internal medicine, 2015-07, Vol.29 (4), p.1098-1104

2015

Volltextzugriff (PDF)

Combination Chemotherapy with Continuous l-Asparaginase, Lomustine, and Prednisone for Relapsed Canine Lymphoma

Journal of veterinary internal medicine, 2009-09, Vol.23 (5), p.1058-1063

2009

Volltextzugriff (PDF)

Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour‐bearing dogs (excluding mast cell tumours): a phase I dose‐finding study

Veterinary & comparative oncology, 2012-09, Vol.10 (3), p.184-193

2012

Volltextzugriff (PDF)

Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases

Journal of Veterinary Medical Science, 2006, Vol.68(6), pp.581-587

2006

Volltextzugriff (PDF)

Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia®) in tumour‐bearing dogs: a phase I dose‐finding study

Veterinary & comparative oncology, 2016-06, Vol.14 (2), p.202-209

2016

Volltextzugriff (PDF)

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase ii clinical trial in canine patients with malignant melanoma

Cancer Immunology, Immunotherapy, 2006-04, Vol.55 (4), p.433-442

2006

Volltextzugriff (PDF)

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose‐finding study

Veterinary & comparative oncology, 2012-09, Vol.10 (3), p.174-183

2012

Volltextzugriff (PDF)

Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in Canine appendicular osteosarcoma

Journal of veterinary internal medicine, 2011-05, Vol.25 (3), p.511-517

2011

Volltextzugriff (PDF)

Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma

Veterinary & comparative oncology, 2016-12, Vol.14 (4), p.e135-e145

2016

Volltextzugriff (PDF)

Phase II clinical evaluation of lomustine chemotherapy for feline vaccine‐associated sarcoma

Veterinary & comparative oncology, 2012-12, Vol.10 (4), p.283-291

2012

Volltextzugriff (PDF)

Rabacfosadine for relapsed canine B‐cell lymphoma: Efficacy and adverse event profiles of 2 different doses

Veterinary & comparative oncology, 2018-03, Vol.16 (1), p.E76-E82

2018

Volltextzugriff (PDF)

Phase I lead‐in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour‐bearing dogs

Veterinary & comparative oncology, 2017-06, Vol.15 (2), p.421-430

2017

Volltextzugriff (PDF)

1 – 25 von 1.126

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(977)
Mit Volltextzugriff
(951)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document

Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document

Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

Conduct, Oversight, and Ethical Considerations of Clinical Trials in Companion Animals with Cancer: Report of a Workshop on Best Practice Recommendations

Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma

Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs

Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer

Efficacy of Radiation Therapy for the Treatment of Sialocele in Dogs

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

Phosphorus(III)-Mediated Stereoconvergent Formal [4+1]-Cycloannulation of 1,2-Dicarbonyls and o‑Quinone Methides: A Multicomponent Assembly of 2,3-Dihydrobenzofurans

Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs

Combination Chemotherapy with Continuous l-Asparaginase, Lomustine, and Prednisone for Relapsed Canine Lymphoma

Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour‐bearing dogs (excluding mast cell tumours): a phase I dose‐finding study

Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases

Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia®) in tumour‐bearing dogs: a phase I dose‐finding study

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase ii clinical trial in canine patients with malignant melanoma

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose‐finding study

Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in Canine appendicular osteosarcoma

Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma

Phase II clinical evaluation of lomustine chemotherapy for feline vaccine‐associated sarcoma

Rabacfosadine for relapsed canine B‐cell lymphoma: Efficacy and adverse event profiles of 2 different doses

Phase I lead‐in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour‐bearing dogs

Suchergebnisse filtern